Value-Based Generic Drug Evaluation Focus on Chinese Real-World Evidence
Сохранить в:
Главные авторы: | Jinmiao Lu (Автор), Xiaohua Ying (Автор), Zhiping Li (Автор) |
---|---|
Формат: | |
Опубликовано: |
Kerman University of Medical Sciences,
2023-12-01T00:00:00Z.
|
Предметы: | |
Online-ссылка: | Connect to this object online. |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Схожие документы
-
Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
по: jinmiao Lu, и др.
Опубликовано: (2023) -
Negotiating Medical Insurance Drug Prices: The Role in Reducing Costs of Orphan Drugs for Rare Diseases
по: Jinmiao Lu, и др.
Опубликовано: (2023) -
Inspiration to mRNA-based COVID-19 vaccination: Serious adverse case reports with hepatitis B vaccine in real-world
по: Jinmiao Lu, и др.
Опубликовано: (2022) -
First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world
по: Jinmiao Lu, и др.
Опубликовано: (2022) -
Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study
по: Finocchietti M, и др.
Опубликовано: (2024)